To access the full text documents, please follow this link: http://hdl.handle.net/2445/110769
Title: | Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway |
---|---|
Author: | Chaccour, Carlos; Rabinovich, Regina |
Abstract: | The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in order to help guide trial design. The rationale for a particular timing of an ivermectin-based tool and some potentially useful outcome measures are suggested. |
Subject(s): | -Malària -Assaigs clínics -Malaria -Clinical trials |
Rights: | cc by (c) Chaccour et al., 2017
http://creativecommons.org/licenses/by/3.0/es/ |
Document type: | Article Article - Published version |
Published by: | Biomed Central |
Share: |